Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells

Experimental Biology and Medicine

Volumn 235, Issue 7, 2010, Pages 886-891

  Rizvi, Maleeha ^a   Jawad, Noorulhuda ^a   Li, Yuantao ^b   Vizcaychipi, Marcela P ^a   Maze, Mervyn ^c   Ma, Daqing ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ischemia reperfusion injury; Noble gas; Oxygen glucose deprivation; Preconditioning; Renoprotection

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ARGON; CARBON DIOXIDE; GLUCOSE; HELIUM; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INERT GAS; KRYPTON; NEON; OXYGEN; PROTEIN BCL 2; XENON;

ADULT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; PROTEIN EXPRESSION; RENAL PROTECTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANOXIA; ARGON; BLOTTING, WESTERN; CELL LINE; GLUCOSE; HELIUM; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIC PRECONDITIONING; KIDNEY TUBULES; KRYPTON; NEON; NOBLE GASES; PROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; REPERFUSION INJURY; XENON;

EID: 77953801719     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.009366     Document Type: Article

References (39)

1. Swaminathan M, Stafford-Smith M. Renal dysfunction after vascular surgery. Curr Opin Anaesthesiol 2003;6:45-51
2. Zacharias M, Gilmore IC, Herbison GP, Sivalingam P, Walker RJ. Interventions for protecting renal function in the perioperative period. Anesth Analg 2005;101:1558
3. 2 deprivation injury, possibly by inducing uremia. Kidney Int 1994;45:1760-8
4. Bonventre JV. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 2002;11:43-8
5. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion- induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001;276:1870-6 (Pubitemid 33650162)
6. Minguet G, Joris J, Lamy M. Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics? Eur J Anaesthesiol 2007;24:733-45
7. Koblin DD, Fang Z, Eger EI, Laster MJ, Gong D, Ionescu P, Halsey MJ, Trudell JR. Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics). Anesth Analg 1998;87:419-24 (Pubitemid 28369104)
8. Ma D, Hossain M, Pettet GK, Luo Y, Lim T, Akimov S, Sanders RD, Franks NP, Maze M. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab 2006;26:199-208 (Pubitemid 43151576)
9. Wilhelm S, Ma D, Maze M, Franks NP. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 2002;96:1485-91 (Pubitemid 34587220)
10. Coburn M, Maze M, Franks NP. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med 2008;36:588-95 (Pubitemid 351158637)
11. David HN, Haelewyn B, Chazalviel L, Lecocq M, Degoulet M, Risso JJ, Abraini JH. Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia. J Cereb Blood Flow Metab 2009;29:1159-65
12. Preckel B, Mullenheim J, Moloschavij A, Thamer V, Schlack W. Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 2000;91:1327-32
13. Weber NC, Toma O, Wolter JI, Obal D, Mullenheim J, Preckel B, Schlack W. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Br J Pharmacol 2004;144:123-32 (Pubitemid 40188554)
14. Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, Warltier DC, Pratt PF. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signalling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 2007;105:562-9 (Pubitemid 47300827)
15. Yarin YM, Amarjargal N, Fuchs J, Haupt H, Mazurek B, Morozova SV, Gross J. Argon protects hypoxia-, cisplatin- and gentamycin-exposed hair cells in the newborn rat's organ of Corti. Hear Res 2005;201:1-9 (Pubitemid 40255539)
16. Ma D, Lim T, Xu J, Tang H, Wan Y, Zhao H, Hossain M, Maxwell PH, Maze M. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol 2009;20:713-20
17. Imamura R, Moriyama T, Isaka Y, Namba Y, Ichimaru N, Takahara S, Okuyama A. Erythropoietin protects the kidneys against ischemia-reperfusion injury by activating hypoxia inducible factor-1alpha. Transplantation 2007;83:1371-9 (Pubitemid 46800315)
18. Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci 1993;13:3510-24
19. Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br J Anaesth 2002;89:739-46
20. Dickinson R, Peterson BK, Banks P, Simillis C, Martin JC, Valenzuela CA, Maze M, Franks NP. Competitive inhibition at the glycine site of the N-methyl-D aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular signalling and electrophysiology. Anesthesiology 2007;107:756-67 (Pubitemid 351325968)
21. Scheid MP, Woodgett JR. PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2001;2:760-8
22. Murphy E, Tong H, Steenbergen C. Preconditioning: is the Akt-ion in the PI3K pathway? J Mol Cell Cardiol 2003;35:1021-5
23. Murphy E. Primary and secondary signalling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res 2004;94:7-16 (Pubitemid 38064093)
24. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W. Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 2006;105:187-97 (Pubitemid 44305208)
25. Das DK, Engelman RM, Maulik N. Oxygen free radical signalling in ischemic preconditioning. Ann N Y Acad Sci 1999;874:49-65 (Pubitemid 29351930)
26. Mio Y, Shim YH, Richards E, Bosnjak ZJ, Pagel PS, Bienengraeber M. Xenon preconditioning: the role of prosurvival signalling, mitochondrial permeability transition and bioenergetics in rats. Anesth Analg 2009;108:858-66
27. Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, Manola J, Brugarolas J, McDonnell TJ, Golub TR, Loda M, Lane HA, Sellers WR. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004;10:594-601
28. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 1995;77:1030-5
29. Limatola V, Ward P, Cattano D, Gu J, Giunta F, Maze M, Ma D. Xenon preconditioning confers neuroprotection regardless of gender in a mouse model of transient middle cerebral artery occlusion. Neuroscience 2010;165:874-81
30. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000;88:1474-80
31. Hill P, Shukla D, Tran MG, Aragones J, Cook HT, Carmeliet P, Maxwell PH. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2008;19:39-46
32. Loor G, Schumacker PT. Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ 2008;15:686-90
33. Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, Mehmet H, Edwards AD, Franks NP, Maze M. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005;58:182-93
34. Tsujimoto Y, Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ 2000;7:1174-81
35. Jacobi CA, Wildbrett P, Volk T, Muller JM. Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model. Surg Endosc 1999;13:1021-5
36. Dahn S, Schwalbach P, Wohleke F, Benner A, Kuntz C. Influence of different gases used for laparoscopy (helium, carbon dioxide, room air, xenon) on tumor volume, proliferation, and apoptosis. Surg Endosc 2003;17:1653-7
37. Seto T, Isogai H, Ozaki M, Nosaka S. Noble gas binding to human serum albumin using docking simulation: nonimmobilizers and anesthetics bind to different sites. Anesth Analg 2008;107:1223-8
38. Trudell JR, Koblin DD, Eger EI. A molecular description of how noble gases and nitrogen bind to a model site of anesthetic action. Anesth Analg 1998;87:411-18
39. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, Ma D. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 2009;460:232-6